Clinical significance of neuroendocrine phenotype in non-small-cell lung cancer

Annals of Oncology

Volumn 12, Issue SUPPLE. 2, 2001, Pages

  Carnaghi, C ^a   Rimassa, L ^a   Garassino, I ^a   Santoro, A ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

Chemosensitivity; Chromogranin A; Neuroendocrine differentiation; Non small cell lung cancer; Prognosis; Synaptophysin

Indexed keywords

CHROMOGRANIN A; SYNAPTOPHYSIN;

CANCER CLASSIFICATION; CANCER STAGING; CHEMOSENSITIVITY; CONTROLLED STUDY; DATA ANALYSIS; HISTOPATHOLOGY; HUMAN; LUNG NON SMALL CELL CANCER; OUTCOMES RESEARCH; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REVIEW; STANDARD; SURVIVAL; TECHNIQUE; THEORY; TISSUE DIFFERENTIATION; ULTRASTRUCTURE;

EID: 0035165661     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/12.suppl_2.s119     Document Type: Review

References (15)

1. Expression of neuroendocrine cell-markers L-dopa-decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and non-endocrine origin
2. A comparison of NSP-reticulons with conventional neuroendocrine markers in immunophenotyping of lung cancers
3. Clinical characterization of non-small-cell lung tumors showing neuroendocrine differentiation features
4. Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma
5. Neuroendocrine differentiation and clinical behaviour in non-small-cell lung tumours
6. Impact of neuroendocrine differentiation in non-small-cell lung cancer. The LCSG experience
7. Neural cell adhesion molecule expression. Prognosis in 889 patients with resected non-small-cell lung cancer
8. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small-cell lung cancer
9. Prognostic factors in resected non-small-cell lung cancer: An immunohistochemical study of 39 cases
10. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer
11. Prognostic impact of histologic demonstration of chromogranin A and neuron-specific enolase in pulmonary adenocarcinoma
12. Neuroendocrine differentiation as a prognostic factor in non-small-cell lung cancer
13. Analysis of neuroendocrine markers HER2 and CEA before and after chemotherapy in patients with stage IIIA non-small-cell lung cancer: A Cancer and Leukemia Group B study
14. Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated non-small-cell lung carcinoma
15. Chromogranin A gene expression in non-small-cell lung carcinomas